- Home
- HSDT vs XTNT Comparison
HSDT vs XTNT Comparison
Compare HSDT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSDT | XTNT |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.6M | 88.7M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | HSDT | XTNT |
|---|---|---|
| Price | $2.09 | $0.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | ★ 407.3K | 91.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $53,337,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | $75.13 | N/A |
| P/E Ratio | ★ N/A | $20.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.26 | $0.34 |
| 52 Week High | $25.50 | $0.95 |
Technical Indicators
Market Signals| Indicator | HSDT | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 54.91 |
| Support Level | $1.78 | $0.55 |
| Resistance Level | $2.37 | $0.68 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 53.14 | 61.02 |
Price Performance
Historical ComparisonAbout HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.